Here are the 424B prospectus supplements from Frequency Electronics, Inc. (FEIM) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow FEIM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FEIM filings page.
Frequency Electronics, Inc. is conducting a mixed primary and secondary offering of 1,739,131 shares of common stock at $57.50 per share. The company is issuing 1,086,957 shares, while Edenbrook Value Fund, LP and Edenbrook Long Only Value Fund, LP are selling 652,174 shares they currently hold.
The company expects gross proceeds of $58.75 million (or $72.85 million if underwriters exercise a 260,869‑share option in full) and net proceeds of approximately $58.2 million (or $72.3 million with full option exercise) after estimated expenses. Net proceeds are intended for growth initiatives, including capital expenditures, working capital and other general corporate purposes. Frequency will not receive proceeds from shares sold by the selling stockholders.
Shares outstanding were 9,868,867 as of April 30, 2026 and are expected to increase to 10,955,824, or 11,216,693 if the underwriters’ option is fully exercised. The offering implies underwriting discounts of $3.45 per share and raises cash from $1.6 million to about $59.8 million on an as‑adjusted basis, with total stockholders’ equity rising to $114.6 million.
Frequency Electronics, Inc. plans a mixed primary and secondary offering of up to $100,000,000 of common stock. The company will sell $62,500,000 of common stock, while Edenbrook Value Fund, LP and Edenbrook Long Only Value Fund, LP, affiliates of a board member, will resell $37,500,000 of existing shares; the company will not receive proceeds from the selling stockholders’ sales.
The company has granted underwriters a 30‑day option to buy up to an additional $15,000,000 of common stock from the company. Based on an assumed price of $70.64 per share (the July 27, 2026 Nasdaq closing price), shares outstanding would be 10,753,634, or 10,965,979 if the option is fully exercised, compared with 9,868,867 shares outstanding as of April 30, 2026.
Net proceeds to the company will be used to fund additional growth opportunities, including capital expenditures, working capital and other general corporate purposes. The company highlights risks including stock price volatility, immediate and substantial dilution relative to net tangible book value of $5.69 per share as of April 30, 2026, potential future dilution from additional issuances and equity awards, and stock overhang from existing holders, including the selling stockholders, whose April 30, 2026 beneficial holdings totaled approximately 1,873,810 shares.